The estimated Net Worth of Peter Barrett is at least $17 Million dollars as of 28 May 2020. Mr. Barrett owns over 7,552 units of Revvity stock worth over $2,536,495 and over the last 20 years he sold PKI stock worth over $14,196,110. In addition, he makes $279,976 as Independent Director at Revvity.
Peter has made over 11 trades of the Revvity stock since 2004, according to the Form 4 filled with the SEC. Most recently he sold 7,552 units of PKI stock worth $756,031 on 28 May 2020.
The largest trade he's ever made was selling 341,549 units of Revvity stock on 27 February 2006 worth over $5,406,721. On average, Peter trades about 18,885 units every 91 days since 2004. As of 28 May 2020 he still owns at least 22,001 units of Revvity stock.
You can see the complete history of Mr. Barrett stock trades at the bottom of the page.
Dr. Peter Barrett Ph.D. serves as Independent Director of the Company. He joined Atlas Venture, an early stage life sciences venture capital fund, in 2002 and is a partner in the life sciences group. Previously, he was a co-founder, Executive Vice President and Chief Business Officer of Celera Genomics. Prior to that, Mr. Barrett held several senior management positions at The Perkin-Elmer Corporation, most recently serving as Vice President, Corporate Planning and Business Development. He currently serves as the Chairman of Zafgen, Inc. and Synlogic, Inc., as well as a board member of several privately held companies. Mr. Barrett is also a senior fellow at the Harvard Business School. Mr. Barrett received his Bachelor of Science degree in chemistry from Lowell Technological Institute (now known as the University of Massachusetts, Lowell) and his Doctoral degree in analytical chemistry from Northeastern University.
As the Independent Director of Revvity, the total compensation of Peter Barrett at Revvity is $279,976. There are 10 executives at Revvity getting paid more, with Dr. Prahlad R. Singh Ph.D. having the highest compensation of $4,862,149.
Peter Barrett is 67, he's been the Independent Director of Revvity since 2012. There are no older and 21 younger executives at Revvity.
Peter's mailing address filed with the SEC is C/O SYNLOGIC, INC., 301 BINNEY STREET, SUITE 402, CAMBRIDGE, MA, 02142.
Over the last 26 years, insiders at Revvity have traded over $204,298,889 worth of Revvity stock and bought 55,200 units worth $1,110,570 . The most active insiders traders include Alexis P Michas, Gregory L Summe und Robert F Friel. On average, Revvity executives and independent directors trade stock every 25 days with the average trade being worth of $6,184,617. The most recent stock trade was executed by Andrew Okun on 13 April 2023, trading 2,435 units of PKI stock currently worth $332,402.
PerkinElmer enables scientists, researchers, and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, the company delivers unique solutions to serve the diagnostics, life sciences, food, and applied markets. IT strategically partners with customers to enable earlier and more accurate insights supported by deep market knowledge and technical expertise. Its dedicated team of about 14,000 employees worldwide is passionate about helping customers work to create healthier families, improve the quality of life, and sustain the wellbeing and longevity of people globally. The Company reported revenue of approximately $3.8 billion in 2020, serves customers in 190 countries, and is a component of the S&P 500 index.
Revvity executives and other stock owners filed with the SEC include: